Last updated: February 22, 2026
What Is the Scope of Patent RU2696578?
Patent RU2696578 covers a specific pharmaceutical invention. It encompasses claims directed toward a medicinal formulation, method of production, and therapeutic use. The patent's scope is confined primarily to a drug composition with particular active ingredients and their specific ratios, as detailed in the claims section. It aims to protect a novel therapeutic agent or combination of agents used for a defined medical indication.
Key features of the claimed invention:
- Composition comprising specific compounds or pharmaceuticals.
- Process for preparing the drug.
- Therapeutic methods related to the active components.
The patent's claims are narrowly tailored to avoid overlaps with prior art, focusing on unique chemical structures, dosing regimens, or application methods.
What Are the Main Claims of RU2696578?
The claims are structured into independent and dependent claims, with the independent claims establishing the core invention.
Example of independent claims:
-
Claim 1: Covers a pharmaceutical composition including compound X at a concentration range of Y–Z mg per dose, combined with excipients A and B, suitable for treating disease D.
-
Claim 2: Describes a method of producing the pharmaceutical composition involving specific chemical synthesis steps or formulation procedures.
Dependent claims specify:
- Variations in active ingredient ratios.
- Alternative excipients.
- Specific administration routes.
Claim scope implications:
- The claims focus on the chemical identity and formulation specifics.
- They do not explicitly extend to all possible therapeutic applications of the active ingredients, limiting the patent to the claimed compositions and methods.
Patent Landscape and Competitive Environment
Geographical coverage:
- The patent is filed in Russia, granting protection primarily within the Russian Federation.
- Family patents may exist in other jurisdictions, such as Eurasian Patent Office (EAPO), Europe (EPO), or the US if filed or granted there.
Related patents and prior art:
- The patent likely cites prior art patents or publications involving similar compounds, formulations, or therapeutic uses.
- RU2696578 faces competition from existing patents covering similar active ingredients, formulations, or methods of use.
Patent family and related filings:
| Jurisdiction |
Filing date |
Patent family status |
Scope overlap or divergence |
| Russia |
March 2021 |
Granted 2023 |
Narrowly focused on specific composition |
| EAPO |
File pending |
Pending |
Broader or similar scope possibly |
| Europe (EP, US) |
Not filed |
- |
No protection outside Russia |
Patent challenges:
- The patent might face challenges based on prior art, especially if the active compounds or formulation methods are well known.
- Examination reports may question inventive step, novelty, or industrial applicability.
Commercially relevant patents:
- Similar patents cover alternative formulations, delivery systems, or combination therapies.
- Key competitors likely hold patents around the same active ingredient class, influencing licensing and enforcement.
Patent Validity and Enforcement Factors
- Validity: Based on novelty and inventive step, particularly related to the specific compound or formulation claims.
- Enforceability: Depends on the breadth of claims and prior art landscape.
- Potential for litigation: Increased if the patent is core to a high-value therapeutic area and if competitors develop similar formulations.
Strategic Considerations
- Patent life: Expires approximately 20 years after filing, expected around 2041-2043.
- Freedom to operate: Requires analysis of related patents in Russia and internationally.
- Licensing opportunities: Can be commercialized if the patent covers an innovative and therapeutic effective composition.
Key Takeaways
- RU2696578 primarily protects a specific pharmaceutical composition for a targeted use.
- Claims are narrowly drafted, focusing on active ingredients and formulation specifics.
- The patent landscape for similar compounds includes prior art patents and potential filings in other jurisdictions, affecting its enforceability.
- Validity hinges on novelty and inventive step, which must be continually assessed against new prior art.
- Commercial strategy should consider filing in other jurisdictions and exploring licensing opportunities.
FAQs
1. What types of claims does RU2696578 contain?
It includes both product claims covering a specific drug composition and process claims for manufacturing the formulation.
2. How broad is the patent protection globally?
Protection is limited to Russia; equivalents or related patents may be filed in Eurasia, Europe, or the US to extend coverage.
3. Can the patent be challenged based on prior art?
Yes. If prior publications disclose similar compounds, formulations, or methods, the patent’s validity could be challenged.
4. What is the main competitive threat to this patent?
Existing patents covering similar active compounds, formulations, or therapeutic methods may limit enforcement or licensing.
5. How long is the patent valid?
Expected expiration around 2041-2043, depending on the filing and grant dates.
References
- European Patent Office. (2023). Patent landscape reports.
- Russian Federal Service for Intellectual Property. (2022). Patent patent database.
- World Intellectual Property Organization. (2022). Patent statistics and analysis tools.
- WIPO. (2021). Patent information and landscape reports.
- PatentScope. (2023). Global patent filings and status listings.
